NEW - Annual General Meeting Presentation 2013
Unilife Medical Solutions (NASDAQ: UNIS)
Unilife Medical Solutions (NASDAQ: UNIS) is an emerging medical device manufacturer with business segments that include pre-filled syringes for pharmaceutical companies to deliver injectable medications, sharps safety devices for healthcare facilities, and contract manufacturing of medical devices.
More than two billion prefilled syringes are currently used each year on a global basis and pharmaceutical companies are making the switch to products such as Unilife's safety syringe which are compliant with needle-stick prevention laws (e.g. Federal Needlestick Prevention Act, 2000).
Key differentiating features of Unilife's fully-integrated (within the barrel of the syringe) safety syringes include the following:
1.) a passive needle retraction system that is activated inside the body
2.) healthcare providers / shot administrators control the speed of needle retraction
3.) auto-disabling prevents re-use or tampering with used syringes.
The market opportunity for prefilled syringes includes 50 drugs (primary anti-coagulant / hematology medications, vaccines, and other biological agents) that are delivered by injection, including an estimated 3 billion prefilled syringes in use by 2012.
Unilife has a distinct advantage with a disruptive technology since there are currently no prefilled syringes to deliver medications with fully-integrated safety features so pharmaceutical companies must add these features - which adds to production / shipping costs and increases the overall packaging size by up to 60%, resulting in both waste disposal and marketing issues.
Drug delivery technologies market will reach $224.2 billion by 2017*
*According to Markets and Markets, a full service market research company
Investor and Analyst Enquiries
As an emerging global leader in innovative safety medical devices, Unilife welcomes enquiries from shareholders and analysts. If you are interested in Unilife investment opportunities, have questions or require more information, please contact the appropriate party below:
Shareholder / Analyst Enquiries United States:
Todd Fromer / Garth Russell - 212-682-6300
Shareholder / Analyst Enquiries Australia: Jeff Carter (Ph: + 61 2 8346 6500)
RECENT CONFERENCE TRANSCRIPTS
Piper Jaffray 25th Annual Healthcare Conference - 12/4/13
UNILIFE in the News / Press Releases
Financial Summary - 2013
"Designed by leading U.S. pharmaceutical architects, our modern $40MM global headquarters and production facility is situated on a 35 acre site in York, PA and sets a new standard for high-quality product manufacturing.
The 165,000 square-foot facility is as an integrated center for product innovation and commercial manufacturing, bringing together under one roof a seamless array of advanced operational capabilities, concentrated industry expertise and efficient quality assurance systems."
Australian Stock Price Chart (1/6th of US price)
Seeking Alpha BioMedReports.com
Unilife Medical: Report Downloads
PRESENTATION (February 2010)
SPAM messages & OFF TOPIC will be deleted.